1,3-dipropyl-8-(4-sulfophenyl)xanthine and captopril

1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with captopril in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Ho, WY; Kuan, CJ; Lin, HC; Tseng, CJ; Tung, CS1
Chan, JY; Jan, CR; Lo, WC; Tseng, CJ1
Albino-Teixeira, A; Morato, M; Sousa, T1

Other Studies

4 other study(ies) available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and captopril

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Modulatory effects of endogenous adenosine on epinephrine secretion from the adrenal medulla of the rat.
    Hypertension (Dallas, Tex. : 1979), 1994, Volume: 24, Issue:6

    Topics: Adenosine; Adrenal Medulla; Animals; Captopril; Epinephrine; Hydralazine; Hypotension; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Xanthines

1994
Modulation of catecholamine release by endogenous adenosine in the rat adrenal medulla.
    Journal of biomedical science, 2001, Volume: 8, Issue:5

    Topics: Adenosine; Adrenal Medulla; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Catecholamines; Epinephrine; Injections, Intravenous; Insulin; Male; Norepinephrine; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Xanthines

2001
Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors.
    European journal of pharmacology, 2002, Apr-19, Volume: 441, Issue:1-2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Blood Pressure; Body Weight; Captopril; Cell Size; Heart; Hypertension; Hypertrophy; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Organ Size; Oxidopamine; Peptidyl-Dipeptidase A; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Sympathectomy; Sympatholytics; Tail; Xanthines

2002